BeOne Medicines (BEIGF) Interest & Investment Income (2015 - 2026)
BeOne Medicines (BEIGF) reported Interest & Investment Income of $27.7 million for Q1 2026, up 115.28% year-over-year from $12.8 million in Q1 2025, and down 52.41% quarter-over-quarter from $58.1 million in Q4 2025.
BeOne Medicines (BEIGF) Interest & Investment Income (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 6 years of Interest & Investment Income data on file, last reported at $27.7 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $27.7 million, up 115.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $92.3 million (up 39.18% YoY), and the FY2025 annual result was $70.5 million, up 1.24% from the prior year.
- Interest & Investment Income declined to $27.7 million in Q1 2026 per BEIGF's latest filing, from $58.1 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $58.1 million in Q4 2025 and troughed at $3.0 million in Q3 2025.
- A 4-year average of $20.2 million and a median of $16.2 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income plunged 73.56% in 2025, then surged 115.28% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $20.6 million in 2023, then surged by 43.49% to $29.6 million in 2024, then surged by 96.3% to $58.1 million in 2025, then sank by 52.41% to $27.7 million in 2026.
- Business Quant data shows BEIGF's Interest & Investment Income at $27.7 million in Q1 2026, $58.1 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -14.79 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 27.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.66 Mn |
| Dec 31, 2025 | 58.13 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 12.85 Mn |
| Dec 31, 2024 | 29.61 Mn |
| Sep 30, 2024 | 10.64 Mn |
| Jun 30, 2024 | 13.23 Mn |
| Mar 31, 2024 | 16.16 Mn |
| Dec 31, 2023 | 20.64 Mn |
| Sep 30, 2023 | 26.65 Mn |
| Sep 30, 2016 | 209,000.00 |
| Jun 30, 2016 | 262,000.00 |
| Mar 31, 2016 | 494,000.00 |
| Sep 30, 2015 | 760,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Mar 31, 2015 | 117,000.00 |